Molecular pathogenesis of ovarian clear cell carcinoma

被引：31
作者：
Gounaris, Ioannis [1 ]
Brenton, James D. [1 ]
机构：
[1] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England
来源：
FUTURE ONCOLOGY | 2015年 / 11卷 / 09期
关键词：
ARID1A; endometriosis; genetically engineered mouse models; glycogen; HNF1B; ovarian clear; PIK3CA cell cancer; IDENTIFIES FREQUENT MUTATION; ARID1A PROTEIN EXPRESSION; SWI/SNF-RELATED COMPLEXES; HYPOXIA-INDUCIBLE FACTOR; REMODELING GENE ARID1A; ENDOMETRIAL CANCER; THERAPEUTIC TARGET; GLYCOGEN-SYNTHESIS; TUMOR-SUPPRESSOR; PTEN EXPRESSION;
D O I：
10.2217/fon.15.45
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ovarian clear cell carcinoma is a distinct subtype of epithelial ovarian cancer, characterized by an association with endometriosis, glycogen accumulation and resistance to chemotherapy. Key driver events, including ARID1A mutations and HNF1B overexpression, have been recently identified and their functional characterization is ongoing. Additionally, the role of glycogen in promoting the malignant phenotype is coming under scrutiny. Appreciation of the notion that ovarian clear cell carcinoma is essentially an ectopic uterine cancer will hopefully lead to improved animal models of the disease, in turn paving the way for effective treatments.
引用
收藏
页码：1389 / 1405
页数：17
相关论文
共 50 条
  • [31] Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?
    Sun, Yue
    Liu, Guoyan
    JOURNAL OF CANCER, 2021, 12 (22): : 6773 - 6786
  • [32] Tumor Suppressive Role of the PRELP Gene in Ovarian Clear Cell Carcinoma
    Dozen, Ai
    Shozu, Kanto
    Shinkai, Norio
    Ikawa, Noriko
    Aoyama, Rina
    Machino, Hidenori
    Asada, Ken
    Yoshida, Hiroshi
    Kato, Tomoyasu
    Hamamoto, Ryuji
    Kaneko, Syuzo
    Komatsu, Masaaki
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (12):
  • [33] Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea
    Kim, Se Ik
    Ha, Hyeong In
    Eoh, Kyung Jin
    Lim, Jiwon
    Won, Young-Joo
    Lim, Myong Cheol
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] A Clearer View of the Molecular Complexity of Clear Cell Renal Cell Carcinoma
    Frew, Ian J.
    Moch, Holger
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10, 2015, 10 : 263 - 289
  • [35] Targeting DNA Damage Response Pathway in Ovarian Clear Cell Carcinoma
    Wong, Oscar G. W.
    Li, Jing
    Cheung, Annie N. Y.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma
    Ayhan, Ayse
    Mao, Tsui-Lien
    Seckin, Tamer
    Wu, Chen-Hsuan
    Guan, Bin
    Ogawa, Hiroshi
    Futagami, Masayuki
    Mizukami, Hiroki
    Yokoyama, Yoshihito
    Kurman, Robert J.
    Shih, Ie-Ming
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) : 1310 - 1315
  • [37] Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma
    Takahashi, Kazuaki
    Takenaka, Masataka
    Kawabata, Ayako
    Yanaihara, Nozomu
    Okamoto, Aikou
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 425 - 431
  • [38] Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma
    Shin, Ha-Yeon
    Yang, Wookyeom
    Chay, Doo Byung
    Lee, Eun-ju
    Chung, Joon-Yong
    Kim, Hyun-Soo
    Kim, Jae-Hoon
    MOLECULAR ONCOLOGY, 2021, 15 (04) : 987 - 1004
  • [39] Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?
    Gounaris, Ioannis
    Charnock-Jones, D. Stephen
    Brenton, James D.
    JOURNAL OF PATHOLOGY, 2011, 225 (02) : 157 - 160
  • [40] Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis
    Suda, Kazuaki
    Diaz, Luis Antonio Cruz
    Yoshihara, Kosuke
    Nakaoka, Hirofumi
    Yachida, Nozomi
    Motoyama, Teiichi
    Inoue, Ituro
    Enomoto, Takayuki
    CANCER SCIENCE, 2020, 111 (08) : 3000 - 3009
12345